4Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA, 1998, 279:1615-1622.
5Black DM, Bakker-Arkema RG, Nawrocki JW. An overview of the clinical safety profile of atorvastatin (lipitor), a new HMG-CoA reductase inhibitor. Arch Intern Med, 1998, 158:577-584.
6Stein E. Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safety. Am J Cardiol, 1998, 82:40J-46J.
7Keogh A, Macdonald P, Kaan A, et al. Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation. J Heart Lung Transplant, 2000, 19:529-537.
8Kantola T, Kivisto KT, Neuvonen PJ. Effect of itraconazole on cerivastatin pharmacokinetics. Eur J Clin Pharmacol, 1999, 54:851-855.
9Plotkin E, Bernheim J, Ben-Chetrit S, et al. Influenza vaccine -a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate. Nephrol Dial Transplant, 2000 ,15:740-741.
10Duell PB, Connor WE, Illingworth DR. Rhabdomyolysis after taking atorvastatin with gemfibrozil. Am J Cardiol, 1998, 81:368-369.
2B Ovbiagele,J L. Saver,S Starkman,D Kim,L K. Ali,R Jahan,G R. Duckwiler,F Vi?uela,S Pineda,D S. Liebeskind.Statin enhancement of collateralization in acute stroke[J]. Neurology . 2007 (24)
